With the development of science and technology, more and more excellent properties of polymer materials have been continuously discovered. COP vials are a typical representative of new materials used in the field of pharmaceutical packaging. Thanks to its many excellent properties, COP vials are suitable for high value-added drugs such as anti-cancer, anti-tumor, rheumatic, and protein.
RTU(ready to use) 2ml COP vial
Polymer Vials have high transparency, low birefringence, low water absorption, high rigidity, high heat resistance, low protein adsorption, and good water vapor airtightness. They can be stored in liquid nitrogen and meet FDA standards. According to incomplete statistics, the list of drugs applicable to COP vials is as follows:
Avastin (bevacizumab) Herceptin (trastuzumab for injection), adalimumab (Humira), palivizumab (alias palivizumab), <medical> anthrax (disease) , combined with chlorambucil, belimumab, treatment of systemic lupus erythematosus, alemtuzumab, certolizumab, trastuzumab, trastuzumab <antineoplastic drug>, diabetes, Raney Buzumab Injection, Opdivo, Pertuzumab, Golimumab, Panitumumab, Primumab, Erbitux, Infliximab, Rituximab ( MabThera), etanercept, darbepoetin alfa, interferon β-1b, rituximab <antineoplastic drug>, interferon β-1a, neurasta, aflibercept, gonadotropin Hormone, anakinra <interleukin receptor blocker>, pegaspargase injection.
The above is the list of drugs that are suitable for Polymer vial packaging known in the market. With the continuous advancement of the technology of the pharmaceutical industry, more new drugs will continue to come out, and the application range of Polymer vials will become more common.
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
MAKE AN ENQUIRY
